Related Experiment Video

Updated: Dec 29, 2025

Isolation of Endocardial and Coronary Endothelial Cells from the Ventricular Free Wall of the Rat Heart
08:22

Isolation of Endocardial and Coronary Endothelial Cells from the Ventricular Free Wall of the Rat Heart

Published on: April 15, 2020

19.3K

Lysosomal Abnormalities in Cardiovascular Disease

Congwu Chi1,2,3,4, Andrew S Riching1,2,3,4, Kunhua Song1,2,3,4

  • 1Division of Cardiology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.

International Journal of Molecular Sciences
|February 5, 2020
PubMed

Insights

Lysosomes are vital for cellular health and cardiovascular function. A new study reveals how cardiomyocytes use a unique mechanism involving LAMP-2B for autophagosome-lysosome fusion, potentially impacting heart disease therapies.

Area of Science:

  • Cell Biology
  • Cardiovascular Science
  • Pathology

Background:

  • Lysosomes are crucial for cellular waste removal and are implicated in numerous human diseases.
  • Proper lysosome function is essential for maintaining cardiovascular system health.
  • Understanding lysosome-cardiovascular disease links is critical for therapeutic advancements.

Purpose of the Study:

  • To review current knowledge on the relationship between lysosome function and cardiovascular diseases.
  • To highlight a recent discovery in cardiomyocyte autophagosome-lysosome fusion.
  • To explore the therapeutic potential of this finding.

Main Methods:

  • Literature review of studies on lysosomes and cardiovascular diseases.
  • Focus on research detailing autophagosome-lysosome fusion mechanisms.
  • Analysis of the role of lysosomal membrane protein LAMP-2B in cardiomyocytes.

Main Results:

  • Cardiomyocytes utilize a distinct autophagosome-lysosome fusion process.
  • This mechanism involves the lysosomal membrane protein LAMP-2B.
  • This finding offers new insights into cellular clearance in the heart.

Conclusions:

  • The characterization of LAMP-2B-mediated fusion provides a novel understanding of lysosomal function in cardiomyocytes.
  • This breakthrough may pave the way for new therapeutic strategies targeting cardiovascular diseases.
  • Further research into this mechanism could enhance cellular clearance and heart health.

Keywords:
Danon diseaseautophagycardiovascular diseaselysosome function

More Related Videos

Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients09:16

Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients

Published on: February 28, 2018

8.0K

Related Concept Videos

Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.4K
Cardiovascular System Abnormal Findings I: Inspection and Palpation01:29

Cardiovascular System Abnormal Findings I: Inspection and Palpation

In a cardiovascular examination, inspection and palpation are crucial for identifying abnormalities.
Abnormal findings observed during an inspection
748
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
427
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
307
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
305
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
385